Login    Join free Add to favorites    中文
home > news > Agilent Technologies and Transcriptic Collaborate to Automate Discovery Biology
Industry Updates | New Products | Supplier News | Upcoming Events | business | web
Agilent Technologies and Transcriptic Collaborate to Automate Discovery Biology

hits:191     Date:12/09/16
SANTA CLARA, Calif., Dec 8, 2016 -- Agilent Technologies Inc. (NYSE: A) and Transcriptic Inc. have agreed to partner their technologies to provide a solution for convenient, broad scale synthetic and discovery biology research.
 
Agilent continues its strong program of fostering innovation using the Agilent portfolio by collaborating with rising companies such as Transcriptic to develop novel synthetic biology solutions. Transcriptic's automated discovery biology platform enables scalable life science research through a convenient and simple web interface. Biologists who use the platform can control their science and generate data remotely via the cloud.

Transcriptic will add multiple Agilent Genomics product lines for mutagenesis and cloning to the protocol library within the Transcriptic robotic cloud laboratory. The first in the series 鈥 QuikChange Lightning 鈥 will accelerate the generation of multiple mutants for large protein function projects. Providing cutting-edge Agilent bioreagents in a robotic laboratory setting will allow a global customer base to automate and optimize workflows for rapid and efficient research discoveries.
 
"We're excited to combine our genome engineering tools with automated experimentation," said Herman Verrelst, Agilent vice president and general manager of the company's Genomics Solutions Division and Clinical Applications Division. "Transcriptic's services are validated, scalable, and accessible from anywhere in the world, which will enhance the market for our industry-leading reagents."
 
The companies recently presented the combined solution at the iGEM 2016 Giant Jamboree to teams of budding synthetic biologists from around the world.
 
 
About Agilent Technologies
Agilent Technologies Inc. (NYSE: A), a global leader in life sciences, diagnostics and applied chemical markets, is the premier laboratory partner for a better world. Agilent works with customers in more than 100 countries, providing instruments, software, services and consumables for the entire laboratory workflow. Agilent generated revenue of $4.20 billion in fiscal 2016. The company employs about 12,500 people worldwide. Information about Agilent is available atwww.agilent.com.
 
Related News>> more
advertisement

Copyright(C) 2006-2017 Bio-Equip    E-mail:web@bio-equip.cn   娌狪CP澶06040519鍙